|
|
 |
POTASSIUM SORBATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POVIDONE K90 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYOXYL 40 STEARATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
FD&C YELLOW NO. 6 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POTASSIUM PHOSPHATE, MONOBASIC Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|